17Jul 2024
Tebentafusp induces a T cell driven rash in melanocyte-bearing skin as an adverse event

Tebentafusp induces a T cell driven rash in melanocyte-bearing skin as an adverse event

Tebentafusp, a gp100xCD3 bispecific ImmTAC, induces rash as an off-tumor, on-target effect by recruiting T cells to melanocytes in the skin. Rash development is linked to baseline gp100 expression. Despite this, rash occurrence does not impact overall survival.

  • #dermatology

Like

Save

Share